Is LENSAR (LNSR) a Deeply Undervalued Stock?
BTIG Maintains LENSAR(LNSR.US) With Hold Rating
Analysts' Opinions Are Mixed on These Healthcare Stocks: Lucid Diagnostics (LUCD), LENSAR (LNSR) and 60 Degrees Pharmaceuticals, Inc. (SXTP)
BTIG Downgrades LENSAR(LNSR.US) to Hold Rating
Express News | LENSAR Inc : Btig Cuts to Neutral From Buy
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating LENSAR, Inc. Buyout
Lake Street Downgrades LENSAR(LNSR.US) to Hold Rating, Raises Target Price to $15
LENSAR Analyst Ratings
Lake Street Downgrades LENSAR to Hold From Buy, Price Target Is $15
Lake Street Reaffirms Their Buy Rating on LENSAR (LNSR)
Express News | LENSAR Shares Down 2.1% Premarket After Alcon Agrees to Acquire Co
Alcon to Acquire Lensar for $430 Million
Alcon to Buy Lensar in Deal Worth Up to $430M
Alcon: Additional Non-Tradeable Contingent Value Right Offering Up to $2.75 Per Shr in Cash, Conditioned on Achievement of 614,000 Cumulative Procedures With LENSAR's Products Between Jan 1, 2026, and Dec 31, 2027 >ALC
Lensar Transaction Is Anticipated to Close in Mid-To-Late 2025 >LNSR
Lensar: Total Potential Consideration of $16.75 Per Shr Assuming Milestones Met, Representing a Total Consideration of Up to $430M >LNSR
Express News | Alcon AG - Transaction Represents Total Consideration of up to $430 Million
Express News | Alcon Agrees to Acquire LENSAR, Inc.
Alcon Agrees To Acquire LENSAR, Inc. LNSR
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup